PMO acts on pharma MSMEs 'crisis call'

The PMO has been alerted to potential medicine shortages and price increases due to stringent regulatory actions on pharmaceutical quality. The Federation of Pharma Entrepreneurs warns that many MSMEs face closure due to costly GMP upgrades, potentially impacting the supply of essential medicines and causing significant job losses. They are urging the government to extend the compliance deadline.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gWrq3Yc
via IFTTT